|
...RNAs (siRNA), and delivery systems for DNA/RNA-based drugs. Upon closing, Genta will issue approximately $13 million in Genta stock to Salus shareholders as an upfront payment. Contingent upon the achievement of certain preclinical and clinical milestones, an additional $17 million dollars may be paid in stock or cash at Genta's option. The purchase of Salus by Genta has been approved by the Boards of Directors of both companies and by a majority of the...
NOTE: All illustrations and photos
have been removed from this article.
More articles from BIOTECH Patent News
Novozymes obtains United States patent.(Novozymes A/S patents a varian..., August 01, 2003
Chui obtains United States patent.(for a method for isolating a gene o..., August 01, 2003
Xiao obtains United States patent.(Xiao patents genetically altered ma..., August 01, 2003
Michigan State University obtains United States patent.(for a human ge..., August 01, 2003
Vlaams Interuniversitair Instituut Voor Biotechnologie obtains United ..., August 01, 2003
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
